Local Coverage
KESIMPTA® (ofatumumab) coverage is better than ever!
*Based on Managed Markets Insight & Technology, LLC database as of May 2024.1
†81% of patients with commercial insurance have first line coverage.2
‡Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual copay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at start.kesimpta.com.
§Based on prescription data collected from April to September 2023.3
Find Coverage
Use this tool to find coverage in your area.
Alongside™ KESIMPTA
We want to make onboarding seamless, so you can focus on your patients
Support for your office
Dedicated Access Reimbursement Manager
- Helps navigate the prior authorization and appeals process
- Helps troubleshoot any coverage or reimbursement issues
Support for your patients
We'll automatically enroll your patients in Alongside KESIMPTA for support and assistance throughout their first year on treatment. Dedicated Coordinators tailor support so patients are prepared, not overwhelmed.
For full details about Alongside KESIMPTA, download our brochure.
Helpful Templates
Templates to help navigate insurance coverage
Looking for Prior Authorization forms? Visit the Getting Started page.
Download Sample Letter of Medical Necessity—New Treatment
Download Sample Letter of Appeal—Change to Treatment
Download Sample Letter of Appeal—New Treatment
Download Sample Letter of Medical Necessity—Change of Treatment
Contact your Sales Representative for a Sensoready® Demo Pen